Cargando…
A Roadmap for the Production of a GMP-Compatible Cell Bank of Allogeneic Bone Marrow-Derived Clonal Mesenchymal Stromal Cells for Cell Therapy Applications
BACKGROUND: Allogeneic mesenchymal stromal cells (MSCs) have been used extensively in various clinical trials. Nevertheless, there are concerns about their efficacy, attributed mainly to the heterogeneity of the applied populations. Therefore, producing a consistent population of MSCs is crucial to...
Autores principales: | Pakzad, Mohammad, Hassani, Seyedeh Nafiseh, Abbasi, Fatemeh, Hajizadeh-Saffar, Ensiyeh, Taghiyar, Leila, Fallah, Nasrin, Haghparast, Newsha, Samadian, Azam, Ganjibakhsh, Meysam, Dominici, Massimo, Baharvand, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852915/ https://www.ncbi.nlm.nih.gov/pubmed/35175538 http://dx.doi.org/10.1007/s12015-022-10351-x |
Ejemplares similares
-
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
por: Zarrabi, Morteza, et al.
Publicado: (2023) -
Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells
por: Tayebi, Behnoosh, et al.
Publicado: (2022) -
Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination
por: Barati, Mojgan, et al.
Publicado: (2021) -
Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies
por: Ramezankhani, Roya, et al.
Publicado: (2020) -
Rheumatoid arthritis: the old issue, the new therapeutic approach
por: Babaahmadi, Mahnaz, et al.
Publicado: (2023)